173091-97-9

Usage

Uses

Used in Pharmaceutical Research:
[(3S)-oxolan-3-yl] N-[(2S,3S)-4-[(2S)-2-benzyl-4-[(2S)-2-(2-methylpropyl)-3-oxo-4-[(1R)-2-phenyl-1-(tert-butylcarbamoyl)ethyl]-1H-pyrrol-2-yl]-3-oxo-1H-pyrrol-2-yl]-3-hydroxy-1-phenyl-butan-2-yl]carbamate is used as a compound for pharmaceutical research due to its complex structure and multiple functional groups, which may exhibit various biological activities.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, [(3S)-oxolan-3-yl] N-[(2S,3S)-4-[(2S)-2-benzyl-4-[(2S)-2-(2-methylpropyl)-3-oxo-4-[(1R)-2-phenyl-1-(tert-butylcarbamoyl)ethyl]-1H-pyrrol-2-yl]-3-oxo-1H-pyrrol-2-yl]-3-hydroxy-1-phenyl-butan-2-yl]carbamate is used as a starting material or a structural component for the development of new drugs, given its unique stereochemistry and functional groups that can be tailored for specific therapeutic targets.
Used in Drug Delivery Systems:
[(3S)-oxolan-3-yl] N-[(2S,3S)-4-[(2S)-2-benzyl-4-[(2S)-2-(2-methylprop yl)-3-oxo-4-[(1R)-2-phenyl-1-(tert-butylcarbamoyl)ethyl]-1H-pyrrol-2-y l]-3-oxo-1H-pyrrol-2-yl]-3-hydroxy-1-phenyl-butan-2-yl]carbamate may also be utilized in the development of drug delivery systems, where its structural features could be exploited to enhance the solubility, stability, or targeted delivery of therapeutic agents.
Used in Chemical Synthesis:
In the broader field of chemical synthesis, [(3S)-oxolan-3-yl] N-[(2S,3S)-4-[(2S)-2-benzyl-4-[(2S)-2-(2-methylpropyl)-3-oxo-4-[(1R)-2-phenyl-1-(tert-butylcarbamoyl)ethyl]-1H-pyrrol-2-yl]-3-oxo-1H-pyrrol-2-yl]-3-hydroxy-1-phenyl-butan-2-yl]carbamate could serve as an intermediate or a building block for the synthesis of more complex molecules with specific applications in various industries.

InChI:InChI=1/C47H58N4O7/c1-31(2)25-47(41(53)37(28-49-47)36(43(55)51-45(3,4)5)23-32-15-9-6-10-16-32)38-29-48-46(42(38)54,26-34-19-13-8-14-20-34)27-40(52)39(24-33-17-11-7-12-18-33)50-44(56)58-35-21-22-57-30-35/h6-20,28-29,31,35-36,39-40,48-49,52H,21-27,30H2,1-5H3,(H,50,56)(H,51,55)/t35-,36+,39-,40-,46-,47-/m0/s1

Upstream product

• 173091-89-9 C₆₀H₇₉N₃O₁₀Si 
• 173092-02-9 (2S,5'S)-5'-Benzyl-5'-((4S,5S)-4-benzyl-3-tert-butoxycarbonyl-2,2-dimethyl-oxazolidin-5-ylmethyl)-4-((R)-1-carboxy-2-phenyl-ethyl)-2-isobutyl-3,4'-dioxo-2,3,4',5'-tetrahydro-[2,3']bipyrrolyl-1,1'-dicarboxylic acid diallyl ester 
• 173092-09-6 (4S,5S)-4-Benzyl-5-[(2S,5'S)-5'-benzyl-4-((R)-1-tert-butylcarbamoyl-2-phenyl-ethyl)-2-isobutyl-3,4'-dioxo-2,3,4',5'-tetrahydro-1H,1'H-[2,3']bipyrrolyl-5'-ylmethyl]-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 173091-90-2 (4S,5S)-4-Benzyl-5-[(2S,5'S)-5'-benzyl-4-((R)-1-carboxy-2-phenyl-ethyl)-2-isobutyl-3,4'-dioxo-2,3,4',5'-tetrahydro-1H,1'H-[2,3']bipyrrolyl-5'-ylmethyl]-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 173092-01-8 (S)-4-[(R)-1-(tert-Butyl-dimethyl-silanyloxymethyl)-2-phenyl-ethyl]-2-isobutyl-2-(3-methyl-but-2-enyl)-3-oxo-2,3-dihydro-pyrrole-1-carboxylic acid allyl ester 
• 173091-86-6 {(S)-4-[(R)-1-(tert-Butyl-dimethyl-silanyloxymethyl)-2-phenyl-ethyl]-2-isobutyl-3-oxo-2,3-dihydro-1H-pyrrol-2-yl}-acetaldehyde 
• 178032-88-7 (S)-4-Benzyl-3-((S)-2-benzyl-5-methyl-hex-4-enoyl)-oxazolidin-2-one 
• 173092-04-1 ((S)-2-Benzyl-5-methyl-hex-4-enyloxy)-tert-butyl-dimethyl-silane 
• 645-45-4 hydrocinnamic acid chloride 
• 173092-00-7 (S)-2-benzyl-5-methyl-hex-4-en-1-ol 
• 173092-05-2 C₃₆H₄₈N₂O₇ 
• 173092-08-5 (4S,5S)-5-((S)-2-Allyloxycarbonylamino-2-methoxycarbonyl-3-phenyl-propyl)-4-benzyl-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 
• 160978-16-5 (2R,4S)-4-Benzyl-4-((2S,3S)-3-tert-butoxycarbonylamino-2-hydroxy-4-phenyl-butyl)-2-tert-butyl-5-oxo-oxazolidine-3-carboxylic acid allyl ester 
• 173240-65-8 (4S,5S)-5-((S)-2-Amino-2-methoxycarbonyl-3-phenyl-propyl)-4-benzyl-2,2-dimethyl-oxazolidine-3-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

Pyrrolinone-based HIV protease inhibitors. Design, synthesis, and antiviral activity: Evidence for improved transport

Pyrrolinone-based peptidomimetics, the first mimics of β-strands, are potent inhibitors of HIV-1 protease. Importantly, the bis(pyrrolinones) described herein proved to be more active in cellular antiviral assays compared with an analogous peptide-derived